BeOne Medicines (ONC) Work In Process (2024 - 2026)

BeOne Medicines (ONC) has 3 years of Work In Process data on file, last reported at $109.2 million in Q1 2026.

• On a quarterly basis, Work In Process changed N/A year-over-year to $109.2 million in Q1 2026; TTM through Mar 2026 was $109.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at $122.7 million, up 104.07% from the prior year.
• Work In Process for Q1 2026 stood at $109.2 million, down from $122.7 million in the prior quarter.
• Over the last five years, Work In Process for ONC reached as high as $122.7 million in Q4 2025 and fell as low as $60.1 million in Q4 2024.
• Historically, Work In Process has averaged $97.3 million across 3 years, with a median of $109.2 million in 2026.
• On a YoY basis, Work In Process climbed as much as 104.07% in 2025 and fell as far as 104.07% in 2025.
• Year by year, Work In Process stood at $60.1 million in 2024, then soared by 104.07% to $122.7 million in 2025, then slipped by 10.98% to $109.2 million in 2026.
• Per Business Quant data, the three most recent Work In Process figures were $109.2 million in Q1 2026, $122.7 million in Q4 2025, and $60.1 million in Q4 2024.